Literature DB >> 16459164

Ferritin subunits in CSF are decreased in restless legs syndrome.

Stacey L Clardy1, Christopher J Earley, Richard P Allen, John L Beard, James R Connor.   

Abstract

Restless legs syndrome (RLS) is a neurological disorder that may be related to iron misregulation at the level of the central nervous system. Evidence that iron is involved in RLS comes from magnetic resonance imaging data, autopsy studies, analyses of cerebrospinal fluid (CSF), and correlations of symptoms with serum ferritin. To further examine the possibility that brain iron status is insufficient in RLS, we determined ferritin levels in the CSF. Specifically, we differentiated between the H- and L-subunits of ferritin, because these peptides are expressed from different chromosomes and have different functions. We measured H- and L-ferritin subunit levels in control and RLS human CSF using immunoblot analysis and found that both H- and L-ferritin are significantly decreased in early but not late-onset RLS. Additionally, we quantified total protein in each CSF sample to establish that the decrease in ferritin subunits in RLS did not reflect a decrease in total protein in CSF. Furthermore, we used equal amounts of total CSF protein in the immunoblot analyses, in contrast to previously published studies that provided only volumetric data, to determine which approach was more accurate for quantifying the amount of ferritin relative to other proteins in CSF. Our results establish a protein standard in RLS, provide a comparative analysis of protein-controlled versus volumetric immunoblot techniques, and argue for a profound loss of iron storage capacity in the brain in RLS, specifically in the early onset RLS phenotype. These data suggest that CSF ferritin levels may provide a biomarker for assisting in the diagnosis of RLS.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16459164     DOI: 10.1016/j.lab.2005.06.011

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  26 in total

Review 1.  Restless legs syndrome: pathophysiology, clinical presentation and management.

Authors:  Claudia Trenkwalder; Walter Paulus
Journal:  Nat Rev Neurol       Date:  2010-06       Impact factor: 42.937

2.  Iron deficiency anemia in infancy exerts long-term effects on the tibialis anterior motor activity during sleep in childhood.

Authors:  Patricio Peirano; Cecilia Algarin; Rodrigo Chamorro; Mauro Manconi; Betsy Lozoff; Raffaele Ferri
Journal:  Sleep Med       Date:  2012-07-04       Impact factor: 3.492

3.  Restless legs syndrome: diagnostic assessment and the advantages and risks of dopaminergic treatment.

Authors:  Birgit Högl; Walter Paulus; Peter Clarenbach; Claudia Trenkwalder
Journal:  J Neurol       Date:  2006-08       Impact factor: 4.849

4.  High-field MRI of brain cortical substructure based on signal phase.

Authors:  Jeff H Duyn; Peter van Gelderen; Tie-Qiang Li; Jacco A de Zwart; Alan P Koretsky; Masaki Fukunaga
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-22       Impact factor: 11.205

Review 5.  A possible role for secreted ferritin in tissue iron distribution.

Authors:  Esther G Meyron-Holtz; Shirly Moshe-Belizowski; Lyora A Cohen
Journal:  J Neural Transm (Vienna)       Date:  2011-02-06       Impact factor: 3.575

6.  Iron-deficiency and dopaminergic treatment effects on RLS-Like behaviors of an animal model with the brain iron deficiency pattern of the restless legs syndrome.

Authors:  Richard P Allen; Christopher J Earley; Byron C Jones; Erica L Unger
Journal:  Sleep Med       Date:  2020-02-05       Impact factor: 3.492

7.  Diurnal cycle influences peripheral and brain iron levels in mice.

Authors:  Erica L Unger; Christopher J Earley; John L Beard
Journal:  J Appl Physiol (1985)       Date:  2008-11-06

8.  Biophysical mechanisms of phase contrast in gradient echo MRI.

Authors:  Xiang He; Dmitriy A Yablonskiy
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-23       Impact factor: 11.205

9.  Restless legs syndrome in pediatric patients with chronic kidney disease.

Authors:  Garrick A Applebee; Ann P Guillot; Catherine C Schuman; Sarah Teddy; Hrayr P Attarian
Journal:  Pediatr Nephrol       Date:  2008-12-02       Impact factor: 3.714

10.  A low-molecular-weight ferroxidase is increased in the CSF of sCJD cases: CSF ferroxidase and transferrin as diagnostic biomarkers for sCJD.

Authors:  Swati Haldar; 'alim J Beveridge; Joseph Wong; Ajay Singh; Daniela Galimberti; Barbara Borroni; Xiongwei Zhu; Janis Blevins; Justin Greenlee; George Perry; Chinmay K Mukhopadhyay; Christine Schmotzer; Neena Singh
Journal:  Antioxid Redox Signal       Date:  2013-04-16       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.